Serum erythropoietin level predicts the prognosis of chronic heart failure with or without anemia

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1327-1331

  Ling, Guo ^a   Wang, Ai Hong ^a   Sun, Yong Le ^a   Lin, Lv ^a   Xu, Chong En ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Erythropoietin; Heart failure; High sensitivity C reactive protein; N terminal pro b type natriuretic peptide; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ARRESTIN 1; C REACTIVE PROTEIN; ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

EID: 84884734557     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1307     Document Type: Article

References (26)

1. Levy D, Kenchaiah S, Larson MG, et al: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402, 2002.
2. Roger VL, Weston SA, Redfield MM, et al: Trends in heart failure incidence and survival in a community-based population. JAMA 292: 344-350, 2004.
3. Agarwal AK and Katz SD: Future directions in management of anemia in heart failure. Heart Fail Clin 6: 385-395, 2010.
4. Tang WH, Tong W, Jain A, et al: Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in latory patients with chronic heart failure. J Am Coll Cardiol 51: 569-576, 2008.
5. Anand IS, Kuskowski MA, Rector TS, et al: Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112: 1121-1127, 2005.
6. O'Meara E, Clayton T, McEntegart MB, et al; CHARM Committees and Investigators: Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 113: 986-994, 2006.
7. Young JB, Abraham WT, Albert NM, et al; OPTIMIZE-HF Investigators and Coordinators: Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 101: 223-230, 2008.
8. Bansal N, Tighiouart H, Weiner D, et al: Anemia as a risk factor for kidney function decline in individuals with heart failure. Am J Cardiol 99: 1137-1142, 2007.
9. Felker GM, Adams KF Jr, Gattis WA and O'Connor CM: Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44: 959-966, 2004.
10. Caramelo C, Justo S and Gil P: Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae. Rev Esp Cardiol 60: 848-860, 2007. (In Spanish).
11. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN and Nanas JN: Anemia in heart failure: pathophysiologic insights and treatment options. Future Cardiol 5: 71-81, 2009.
12. Belonje AM, de Boer RA and Voors AA: Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al." Cardiovasc. Drugs Ther 22: 1-2, 2008.
13. Büyüklü M: Heart failure: erythropoietin in treatment of anemia. Anadolu Kardiyol Derg 7: 342-343, 2007. (In Turkish).
14. Cohen RS, Karlin P, Yushak M, Mancini D and Maurer MS: The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail 16: 96-103, 2010.
15. Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A and Flather MD: Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. Am Heart J 161: 822-831, 2011.
16. Balion C, Santaguida PL, Hill S, et al: Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep) 142: 1-147, 2006.
17. Tsutamoto T, Sakai H, Nishiyama K, et al: Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. Circ J 71: 1873-1878, 2007.
18. Yu CM, Fung JW, Zhang Q, et al: Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure. J Card Fail 11: S42-46, 2005.
19. Lupón J, Urrutia A, González B, et al: Prognostic significance of hemoglobin levels in patients with heart failure. Rev Esp Cardiol 58: 48-53, 2005. (In Spanish).
20. Varadarajan P, Gandhi S, Sharma S, Umakanthan B and Pai RG: Prognostic significance of hemoglobin level in patients with congestive heart failure and normal ejection fraction. Clin Cardiol 29: 444-449, 2006.
21. Akram K and Pearlman BL: Congestive heart failure-related anemia and a role for erythropoietin. Int J Cardiol 117: 296-305, 2007.
22. Ruifrok WP, Qian C, Silljé HH, et al: Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin. J Mol Med (Berl) 89: 377-387, 2011.
23. Timmer SA, De Boer K, Knaapen P, Götte MJ and Van Rossum AC: The potential role of erythropoietin in chronic heart failure: from the correction of anemia to improved perfusion and reduced apoptosis? J Card Fail 15: 353-361, 2009.
24. Ogino A, Takemura G, Kawasaki M, et al: Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia. J Am Coll Cardiol 56: 1949-1958, 2010.
25. Palazzuoli A, Silverberg D, Iovine F, et al: Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 152: 1096. e9-15, 2006.
26. Tang WH and Yeo PS: Epidemiology of anemia in heart failure. Heart Fail Clin 6: 271-278, 2010.